Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03728699 · ClinicalTrials.gov registry record
Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy
A clinical trial, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- 54
- Enrollment target
NCT03728699 is a clinical trial that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 54 participants.
The verdict
NCT03728699 has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
Study Summary
This is a prospective, observational study to collect stool and blood from acute myeloid leukemia patients undergoing intensive chemotherapy.
Interventions
- DIAGNOSTIC_TEST Sample Collection Blood
- DIAGNOSTIC_TEST Stool Sample
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2018-01-02 |
| Est. Completion | 2022-02-18 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03728699
The ClinicalTrials.gov registry entry for NCT03728699 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sample Collection Blood is the first listed.
NCT03728699 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03728699 about?
NCT03728699 is a clinical study titled "Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy". This is a prospective, observational study to collect stool and blood from acute myeloid leukemia patients undergoing intensive chemotherapy.
What is the current status of trial NCT03728699?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2018-01-02. Estimated completion is 2022-02-18.
What interventions are being tested in trial NCT03728699?
The interventions under investigation include: Sample Collection Blood (DIAGNOSTIC_TEST), Stool Sample (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03728699?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.